Investing.com - Inspire Medical Systems (NYSE: INSP) reported first quarter EPS of $-0.34, $0.31 better than the analyst estimate of $-0.65. Revenue for the quarter came in at $164M versus the consensus estimate of $161.41M.
Guidance
Inspire Medical Systems sees FY 2024 EPS of $0.10-$0.20 versus the analyst consensus of $-0.42.
Inspire Medical Systems sees FY 2024 revenue of $783.00M-$793.00M versus the analyst consensus of $782.10M.
Inspire Medical Systems's stock price closed at $245.87. It is up 26.17% in the last 3 months and down -12.91% in the last 12 months.
Inspire Medical Systems saw 2 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Inspire Medical Systems's stock price’s past reactions to earnings here.
According to InvestingPro, Inspire Medical Systems's Financial Health score is "great performance".
Check out Inspire Medical Systems's recent earnings performance, and Inspire Medical Systems's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar